NCT07320066Recruiting
IMT in Asthma: Activity, Coping, Self-Management
Reflections of Inspiratory Muscle Training on Patient Experiences in Asthma Rehabilitation
Source: ClinicalTrials.gov · Last updated 9 Jan 2026
Brief summary (registry, in English)
The aim of this study is to investigate asthma patients' experiences with an 8 week IMT and the perceived effects of this intervention on physical activity, coping strategies, and asthma self-management. A qualitative methodological design will be applied to understand the experiences of patients participating in the IMT program, how the program affected their daily activities, how they coped with symptoms and difficulties, and how they managed their condition.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 15 (estimated)
- First submitted
- 9 Dec 2025
- Start date
- 5 Jan 2026
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Istanbul Esenyurt University
- Diseases
- Asthma
- NCT number
- NCT07320066
What you commit to
- Study type: Observational
- Planned participants: 15
- From 5 Jan 2026 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Having received oral corticosteroid treatment in the last 4 weeks,
- Previous lung surgery, use of long-term oxygen therapy
Other illness
- Having recently had a respiratory tract infection recently (within the last month),
- Having a smoking history of more than 10 pack-years or having a history of smoking within 6 months after quitting smoking
- Eosinophilic Granulomatosis Polyangiitis (EGPA) and Allergic Bronchopulmonary Aspergillosis (ABPA),
- History of malignancy,
- Having accompanying restrictive lung diseases (advanced kyphoscoliosis, ankylosing spondylitis) and neuromuscular diseases (myastania gravis, muscular dystrophies, myopathies) that will prevent healthy respiratory function testing and rehabilitation.
- Cognitive dysfunction, mental retardation, dementia, or other conditions that make it difficult to follow the protocol,
Other
- Having a Body Mass Index \>35,
- Vasculitis,
- Pregnancy,
- Unwillingness to continue participating in the study,
- Communication difficulties or intellectual deficiencies
Who the study is looking for
- Being between the ages of 18-65
- Having been diagnosed with severe persistent, non-allergic asthma by a pulmonologist in accordance with the Global Initiative for Asthma (GINA) guideline criteria,
- Patients with type 2 inflammation markers. According to accepted standards; peripheral eosinophils \<150/µL and/or negative skin prick test and/or total IgE \<30 kU/L
- Bronchodilator response (\>12% or 200 mL improvement in FEV1% predicted following inhalation of 400 mg salbutamol)
- Diagnosis-follow-up period: Patients diagnosed at least 6 months prior, under follow-up and treatment, and/or with controlled asthma
- Having completed the pulmonary rehabilitation program
- Completion of 8 weeks of inspiratory muscle training (IMT)
- Patients who have read, understood, and signed the informed consent form
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul Esenyurt University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.